Dr Piers Daubeney is Reader in Paediatric Cardiology at NHLI, Imperial College London and Consultant Paediatric and Fetal Cardiologist at the Royal Brompton Hospital, Chelsea and Westminster Hospital and 3 district hospitals in the South-East.
He trained at Oxford and St Thomas' Hospitals with postgraduate training at the Wessex Cardiovascular Centre in Southampton, Royal Children's Hospital, Melbourne and the Hospital for Sick Children, Toronto.
Dr Daubeney has a research team and particular interests in the epidemiology and management of congenital heart disease, childhood cardiomyopathy, and drug studies in paediatric heart disease. He has jointly founded the following ongoing international multi-centre studies:
- UK and Ireland Study of Pulmonary Atresia with Intact Ventricular Septum
- National Australian Childhood Cardiomyopathy Study
- UK, Ireland and Sweden Study of Total Anomalous Pulmonary Venous Connection
- UK, Ireland and Sweden Study of Pulmonary Vein Stenosis.
He is also interested in the mechanisms of congenital heart disease and in particular connexin expression. He participates in a number of paediatric multi-centre drug trials in congenital heart disease.
Dr Daubeney has published widely in the field of congenital heart disease and his textbook ‘Diagnosis and Management of Adult Congenital Heart Disease' jointly edited with Professors Gatzoulis and Webb, is now in its third edition having been translated into several different languages.
Dr Daubeney is the lead clinician for paediatric cardiomyopathy at the Royal Brompton Hospital and has an active research programme. He welcomes postgraduate research fellows intending to attain higher qualifications.
et al., 2019, The Ozaki procedure with cardioCel patch for children and young adults with aortic valve disease: preliminary experience - a word of caution, World Journal for Pediatric and Congenital Heart Surgery, Vol:10, ISSN:2150-1351, Pages:724-730
et al., 2019, A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy, Europace, Vol:21, ISSN:1099-5129, Pages:1559-1565
et al., 2019, Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids), Jama Cardiology, Vol:4, ISSN:2380-6583, Pages:918-927
et al., 2019, Left Atrial Strain to Identify Diastolic Dysfunction in Children with Cardiomyopathies, Journal of Clinical Medicine, Vol:8
et al., 2019, NAXDmutations cause a novel neurodegenerative disorder exacerbated by febrile illnesses, 51st Conference of the European-Society-of-Human-Genetics (ESHG) in conjunction with the European Meeting on Psychosocial Aspects of Genetics (EMPAG), NATURE PUBLISHING GROUP, Pages:751-752, ISSN:1018-4813